For Sinoveda, the Proof Is in the Formula
The Canadian Health Brand's Formulations Are Built on Decades of Research and Standardization Thanks to Its Pharmaceutical Platform Technology
Canadian health brand Sinoveda was founded in 2006 with the explicit goal of bringing together the science-backed power of Western medicine with the wisdom of Eastern medicine. In the intervening time, the Sinoveda team has used their decades of experience to develop a unique Pharmaceutical Platform Technology (PPT®). This platform enables them to not only identify the active ingredients in various botanicals and herbs. It also allows for the observation of how these components synergistically interact with each other. This opens up the doors for the creation of standardized, patentable formulas that are filled with natural ingredients.
"You have to look further than ingredients lists for nutraceuticals and other health and wellness solutions to work. The proof is in the formula," explains Dr.
Treating the study and development of natural health solutions with a similar process as pharmaceutical chemicals and synthetics is a revolutionary approach. It enables the Sinoveda team to provide a remarkable sense of consistency and standardization that has hitherto been unseen in the natural health and wellness industry.
Sinoveda's consumer products are designed to work the same every time. PPT® allows for unprecedented molecular research and targeted in-vitro and in-silico testing, which utilizes AI and machine learning. This makes each product easy to clinically test due to its quantifiable formula and expected results.
"When things work in nature, they work in unison. They work as a group," says
Sinoveda's growing catalog of products includes its topical pain reliever Proflexa and its uniquely effective calcium supplement EffectiCal — both of which are available in
About Sinoveda
The name "Sinoveda" is derived from Chinese and Bangladeshi, the two cultures of the company's founders, renowned pharmaceutical scientists and spouses Dr.
Media Contact:
DR. NUZHAT TAM-ZAMAN,
Co-Founder & VP Consumer Health
O• (780) 466-0086 | C• (780) 264-0818
[email protected]
View original content:https://www.prnewswire.com/news-releases/for-sinoveda-the-proof-is-in-the-formula-301972391.html
SOURCE Sinoveda
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- International Study Links Ambient PM2.5 Exposure to Lower Clinical Pregnancy and Live-Birth Rates Following Assisted Reproductive Technology.
- PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti,
- UBS reports 2Q26 net profit of USD 2.8bn and USD 5.8bn for 1H26 with robust momentum across businesses; Group invested assets at USD 7.3trn (Ad hoc announcement pursuant to Article 53 of the SIX Excha
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
VanguardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share